Drug Shortage Report for METRONIDAZOLE INJECTION, USP
Report ID | 220718 |
Drug Identification Number | 00870420 |
Brand name | METRONIDAZOLE INJECTION, USP |
Common or Proper name | Metronidazole Injection |
Company Name | BAXTER CORPORATION |
Market Status | MARKETED |
Active Ingredient(s) | METRONIDAZOLE |
Strength(s) | 5MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 500 mg (JB3401P) |
ATC code | J01XD |
ATC description | OTHER ANTIBACTERIALS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2024-02-26 |
Actual start date | 2024-02-26 |
Estimated end date | 2024-03-15 |
Actual end date | 2024-03-15 |
Shortage status | Resolved |
Updated date | 2024-03-19 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 7125 MISSISSAUGA ROAD MISSISSAUGA, ONTARIO CANADA L5N 0C2 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2024-03-19 | French | Compare |
v3 | 2024-03-19 | English | Compare |
v2 | 2024-02-27 | French | Compare |
v1 | 2024-02-27 | English | Compare |
Showing 1 to 4 of 4